Category Archives: AZBio News
New Technology May Help Surgeons Save Lives
Without having to learn new technical skills or adapt to changes in the operating room, surgeons get a better view of blood flowing inside vessels and a better view of tissues, thanks to new microscopy technology developed at the UA.
Hyalescent Ventures Makes Investment In Beacon Biomedical Inc. to Make Cancer Screening Easy, Accurate and Affordable
Beacon Biomedical, Inc., a privately held company focused on developing patient friendly cancer screening announced that it received an investment from Hyalescent Ventures.Continue reading
Accelerate Diagnostics Reports Positive Results From Pilot Study of Its Investigational ID/AST System and Blood Culture Assay Kit and Initiation of Trial to Support FDA Clearance
Accelerate Diagnostics, Inc. announced positive findings from a multicenter pilot study to evaluate external performance of its ID/AST System and Blood Culture Assay Kit. Based on the results of the study, the company also announced the initiation of its clinical trial for submission to the U.S. Food and Drug Administration.Continue reading
Sinema, Fitzpatrick Jobs Bill Cuts Red Tape for Innovators
WASHINGTON, D.C. – Dec. 1, 2015 – Today, Congresswoman Kyrsten Sinema (AZ-09) and Congressman Mike Fitzpatrick (PA-08) introduced legislation reducing burdensome regulations on small and emerging businesses. The Fostering Innovation Act provides commonsense regulatory relief for companies on the cutting edge of scientific and medical research.
Brain State Technologies Launches Kickstarter Campaign for B-2 Development
B-2 Technology helps the brain deeply relax and rebalance itself for relief from stress, refreshing sleep, and increased performance.Continue reading
NuvOx reports favorable data on Phase 1b clinical trial in Glioblastoma multiforme (GBM)
NuvOx Pharma is a biotechnology company based in Tucson, Arizona with a novel patent portfolio allowing it to develop an innovative platform of dodecafluoropentane (DDFP)-based oxygen therapeutics to treat a host of human conditions.
Continue reading
Making Life Better for a Decade: The 2015 update from C-Path
Critical Path Institute, founded in 2005 in Tucson, Arizona, is an independent, non-profit organization dedicated to bringing scientists from the FDA, industry and academia all together to collaborate and improve the drug development and regulatory process for medical products. Now in it’s tenth year, C-Path President and CEO Martha Brumfield, PhD shares an update on the progress being made. Continue reading
TGen and Barrow Neurological Institute identify genes linked to stress-triggered heart disease
Researchers identify a series of rare genetic changes, showing which patients might be at risk for ‘broken heart syndrome’Continue reading